When Higher Risk Does Not Equal Greater Harm: Doing the Most Good in a Limited Pediatric Study Population.
| Publicado en: | American Journal of Bioethics Vol. 20; no. 4; pp. 118 - 121 |
|---|---|
| Autores principales: | , |
| Formato: | Journal Article |
| Publicado: |
Taylor & Francis Ltd
Apr2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=149496543&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 149496543 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15265161 FKZ jtl: American Journal of Bioethics issn: 15265161 maglogo: N pubinfo: dt: Apr2020 vid: 20 iid: 4 pid: 377 pub: Taylor & Francis Ltd place: Philadelphia, Pennsylvania artinfo: ui: 149496543 10.1080/15265161.2020.1730491 149496543 ppf: 118 ppct: 3 formats: fmt: @attributes: type: P tig: atl: When Higher Risk Does Not Equal Greater Harm: Doing the Most Good in a Limited Pediatric Study Population. aug: au: Matsler, Jeff Young, Jamila M. affil: WellStar Healthcare System sug: subj: Lupus Erythematosus, Systemic Diagnosis Age of Onset In Infancy and Childhood Research, Medical Ethical Issues Research Subject Recruitment Ethical Issues Research Subjects In Infancy and Childhood United States Food and Drug Administration Standards Risk Assessment Child Child: 6-12 years pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|